Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

À§Àå°ü Áõ»óÀ» µ¿¹ÝÇÑ Henoch-Sch nlein Purpura ȯ¾ÆÀÇ Àå°ü ÃÊÀ½ÆÄ ¼Ò°ß ¹× ³»½Ã°æ ¼Ò°ß Intestinal Ultrasonographic and Endoscopic Findings in Pediatric Patients with Henoch-Sch nlein Purpura and Gastrointestinal Symptoms

´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸÁö 2001³â 4±Ç 2È£ p.181 ~ 190
³ëÀ±ÀÏ, ·ù¹ÎÇõ, Á¤Ã¶ÁÖ, À̵¿Áø, ±ÇÁßÇõ,
¼Ò¼Ó »ó¼¼Á¤º¸
³ëÀ±ÀÏ ( Noh Yun-Il ) 
µ¿°­º´¿ø ¼Ò¾Æ°ú

·ù¹ÎÇõ ( Ryu Min-Hyuk ) 
µ¿°­º´¿ø ¼Ò¾Æ°ú
Á¤Ã¶ÁÖ ( Jung Chul-Joo ) 
µ¿°­º´¿ø ¼Ò¾Æ°ú
À̵¿Áø ( Lee Dong-Jean ) 
µ¿°­º´¿ø ¼Ò¾Æ°ú
±ÇÁßÇõ ( Kwon Jung-Hyeok ) 
µ¿°­º´¿ø ¹æ»ç¼±°ú

Abstract

¸ñÀû: À§Àå°ü Áõ»óÀ» °®´Â HSP ȯ¾Æ¿¡¼­ Àå°üÃÊÀ½ÆļҰ߰ú À§³»½Ã°æ°Ë»ç¼Ò°ßÀ» ±Ô¸íÇÏ¿© ÇǺÎÀÚ¹ÝÁõ¾øÀÌ À§Àå°ü Áõ»ó¸¸ Àִ ȯ¾Æ¿¡¼­ HSP Á¶±âÁø´Ü¿¡ Àå°üÃÊÀ½ÆÄ°Ë»ç¿Í À§³»½Ã°æ°Ë»çÀÇ À¯¿ë¼ºÀ» ¾Ë¾Æº¸°íÀÚ º» Á¶»ç¸¦ ½ÃÇàÇÏ¿´´Ù.

¹æ¹ý: 1999³â 1¿ùºÎÅÍ 2001³â 4¿ù±îÁö µ¿°­º´¿ø ¼Ò¾Æ°ú¿¡ ÀÔ¿øÇÑ À§Àå°ü Áõ»óÀ» µ¿¹ÝÇÑ HSP ȯ¾Æ 85¸í 88·Ê¸¦ ´ë»óÀ¸·Î ÀÓ»óÁõ»ó, Àå°üÃÊÀ½ÆļҰ߰ú À§³»½Ã°æ¼Ò°ßÀ» ÈÄÇâÀûÀ¸·Î Á¶»çÇÏ¿´°í µ¿ÀÏÇÑ È¯¾Æ¿¡°Ô¼­ Àå°üÃÊÀ½ÆÄ°Ë»ç¿Í À§³»½Ã°æ°Ë»ç¸¦ µ¿½Ã¿¡ ½ÃÇàÇÑ 4·ÊÀÇ È¯¾Æ¿¡¼­ µÎ °Ë»çÀÇ ¿¬°ü¼ºÀ» ã¾Æº¸¾Ò´Ù.

°á°ú: 1) ÇǺÎÀÚ¹ÝÁõÀÌ 88·Ê(100%) ¸ðµÎ¿¡¼­ ³ªÅ¸³µ°í °üÀýÅë ¹× °üÀýÁõ»óÀÌ 64·Ê(73%), À§Àå°ü Áõ»óÀÌ 52·Ê(59%), ½ÅÀåħ¹ü¼Ò°ßÀÌ 15·Ê(17%), À½³¶Ä§¹ü¼Ò°ßÀÌ 3·Ê(3%)¿¡¼­ ³ªÅ¸³µ´Ù. 2) À§Àå°ü Áõ»óÀº º¹ÅëÀÌ 52·Ê(100%)¿¡¼­ ³ªÅ¸³µ°í
´ëº¯ÀáÇ÷¾ç¼º¹ÝÀÀÀÌ 28·Ê(54%), ±¸¿ª ¹× ±¸Åä°¡ 17·Ê(33%), º¹ºÎ¾ÐÅëÀÌ 17·Ê(33%), Ç÷º¯ ȤÀº Èæ»öº¯ÀÌ 12·Ê(23%), ¼³»ç 6·Ê(12%), ÅäÇ÷ 4·Ê(8%), º¹ºÎ¹Ý»çÅë°ú º¹ºÎ°æÁ÷ÀÌ °¢°¢ 1·Ê(2%)¼øÀ̾ú´Ù. 3) À§Àå°ü Áõ»óÀ» °®´Â 52·Ê Áß 27·Ê¿¡¼­ º¹ºÎÃÊÀ½Æİ˻縦 ½ÃÇàÇÏ¿´´Âµ¥ 22·Ê(81%)¿¡¼­ ÀÌ»ó¼Ò°ßÀÌ ³ªÅ¸³µ´Ù. ½ÊÀÌÁöÀå°ú °øÀ庮ÀÇ ºñÈļҰßÀÌ 16·Ê(73%)·Î¼­ °¡Àå ¸¹¾Ò°í º¹¼ö 8·Ê(36%), Àå°£¸· ÀÓÆļ±Á¾Ã¢ 8·Ê(36%), ÀåÆó»öÁõ 4·Ê(18%), ÀÌ»ó´ã³¶¼Ò°ß 1·Ê(5%)¼øÀ̾ú´Ù. À§Àå°ü Áõ»óÀ» °®Áö ¾Ê´Â 36·ÊÀÇ HSP ȯ¾Æ Áß 3·Ê¿¡¼­ ½Ç½ÃÇÑ º¹ºÎÃÊÀ½ÆÄ°Ë»ç´Â ¸ðµÎ Á¤»ó ¼Ò°ßÀ¸·Î ³ªÅ¸³µ´Ù. 4) 5·ÊÀÇ ³»½Ã°æ ¼Ò°ßÀº Àü·Ê¿¡¼­ À§¼Ò°ßÀº Á¤»óÀ̾ú°í ½ÊÀÌÁöÀå¿¡ ´Ù¹ß¼ºÀÇ ¹Ì¶õ¼º ÃâÇ÷¼º ½ÊÀÌÁöÀå¿°ÀÇ ¼Ò°ßÀ» º¸¿´´Âµ¥ ±¸ºÎº¸´Ù ÇÏÇà½ÊÀÌÁöÀå¿¡ ´õ ½ÉÇßÀ¸¸ç 1·Ê¿¡¼­´Â ±¸ºÎ¼Ò°ßÀº Á¤»óÀ̾ú°í ÇÏÇà½ÊÀÌÁöÀå¿¡¼­¸¸µ¿ÀÏÇÑ ¼Ò°ßÀ» º¸¿´´Ù. ÀÌ Áß 2·Ê¿¡¼­ ½ÃÇàÇÑ ³»½Ã°æÀû »ý°ËÀýÆíÀÇ º´¸®Á¶Á÷ÇÐÀû ¼Ò°ßÀº ±Þ¼º ¿°Áõ¹ÝÀÀ°ú ±¹¼Ò¹Ì¶õ ¹× ÃâÇ÷¼Ò°ßÀ» º¸¿´´Ù. 5) 4·Ê¿¡¼­ ³»½Ã°æ°Ë»ç¿Í º¹ºÎÃÊÀ½Æİ˻縦 °°ÀÌ ½ÃÇàÇÏ¿´´Âµ¥ Á¤»ó¼Ò°ßÀ» º¸ÀÎ 1·Ê¸¦ Á¦¿ÜÇÏ°í´Â ½ÊÀÌÁöÀå°ú °øÀ庮ÀÇ ºñÈļҰßÀÇ ÃÊÀ½ÆļҰßÀ» º¸¿© ¹Ì¶õ¼º ±Ë¾ç¼º ÃâÇ÷¼º ½ÊÀÌÁöÀå¿°ÀÇ ³»½Ã°æ¼Ò°ßÀÌ ÃÊÀ½ÆÄ°Ë»ç»ó ½ÊÀÌÁöÀ庮ÀÇ ºñÈļҰßÀ¸·Î ³ªÅ¸³ª´Â °ÍÀ¸·Î »ý°¢µÇ¾ú´Ù.

°á·Ð: À§Àå°ü Áõ»óÀ» µ¿¹ÝÇÏ´Â HSP ȯ¾Æ¿¡¼­ º¹ºÎÃÊÀ½ÆÄ°Ë»ç´Â HSPÀÇ À§Àå°üº¯È­¸¦ ¹ß°ßÇÏ°í °æ°ú°üÂû¸¦ º¸´Â
°£ÆíÇÏ°í
ºñħ½ÀÀûÀÎ À¯¿ëÇÑ °Ë»ç¹æ¹ýÀ̸ç, HSP ȯ¾Æ¿¡¼­ ³»½Ã°æ°Ë»çÀÇ ÀûÀýÇÑ ÀûÀÀÁõÀº ¾ÆÁ÷ È®¸³µÇ¾î ÀÖÁö ¾ÊÀ¸³ª ÇÏÇà½ÊÀÌÁöÀåÀÇ ÃâÇ÷¼º ¹Ì¶õ¼º ½ÊÀÌÁöÀå¿°ÀÌ ÀÏ°üµÈ ¼Ò°ßÀ¸·Î »ý°¢µÈ´Ù. ÇǺÎÀÚ¹ÝÁõÀÌ ¾øÀÌ ±Þ¼º »óº¹ºÎÅëÁõÀ» µ¿¹ÝÇÏ´Â À§Àå°ü Áõ»ó, ´ëº¯ÀáÇ÷ ¾ç¼º¹ÝÀÀÀÌ
ÀÖÀ»
°æ¿ì, º¹ºÎÃÊÀ½ÆÄ°Ë»ç»ó ½ÊÀÌÁöÀå°ú °øÀ庮ÀÇ ºñÈļҰßÀÌ º¸À̰ųª ȤÀº À§³»½Ã°æ»ó ÃâÇ÷¼º ¹Ì¶õ¼º ½ÊÀÌÁöÀå¿°ÀÇ ¼Ò°ßÀÌ º¸ÀÏ °æ¿ì pathognomonicÇÏÁö´Â ¾ÊÁö¸¸ HSPÀÇ °¡´É¼ºÀ» Ç×»ó ¿°µÎ¿¡ µÎ°í ´Ù¸¥ ÁúȯÀÌ ¹èÁ¦µÇ¸é ºÎ½ÅÇÇÁúÈ£¸£¸ó Åõ¿©¸¦ °í·ÁÇغ¸´Â °ÍÀÌ ÁÁÀ»
°ÍÀ¸·Î
»ý°¢µÈ´Ù.

Purpose: The aim of this study is to investigate the usefulness of intestinal ultrasonography (US) and upper gastrointestinal endoscopy in the early diagnosis of Henoch-Sch nlein purpura (HSP) with the gastrointestinal (GI) symptoms preceding the emergence of the skin lesion.

Methods: The clinical, intestinal US and upper gastrointestinal endoscopic records of 85 patients (88 cases) with GI symptoms relating to HSP presenting between January 1999 and April 2001 were reviewed.

Results: 1) GI symptoms were observed in 52 cases (59%) and skin, joint, renal and scrotal manifestations were observed in 88 (100%), 64 (73%), 15 (17%), 3 cases (3%) respectively. 2) Out of 52 cases with GI symptoms, abdominal pain was observed in all cases (100%). Positive stool occult blood, nausea and vomiting, abdominal tenderness, melena or tarry stool, diarrhea, hematemesis, rebound tenderness and rigidity were observed in 28 (50%), 17 (33%), 17 (33%), 12 (23%), 6 (12%), 4 (8%), 1 (2%) and 1 case (2%) respectively in order of frequency. 3) Intestinal US examination was performed in 27 cases with HSP and GI symptoms (52 cases). Out of 27 sonographic examinations 22 showed abnormal findings. Thickening of the duodeno-jejunal wall was observed in 16 cases (73%). Free peritoneal fluid, enlarged esenteric lymph node, ileus and abnormal gall bladder were seen in 8 (36%), 8 (36%), 4 (18%) and 1 case (5%) respectively. In three cases of HSP without GI symptoms, those changes were absent. 4) In all of five cases with HSP and GI symptoms, endoscopic study showed mucosal edema and multiple hemorrhagic erosions especially at the second portion of the duodenum. Biopsy specimens from the duodenum of 2 cases out of 5 endoscopic examinations showed acute inflammatory infiltrates in the mucosa with hemorrhage. 5) Both intestinal US and endoscopic studies were performed in 4 cases with HSP and GI symptoms simultaneously. Out of 4 those cases, 3 cases showed the thickened duodeno-jejunal
wall on the intestinal US, which suggested erosive hemorrhagic duodenitis by endoscopic findings.

Conclusion: The typical but nonpathognomonic intestinal US findings including the thickening of the duodeno-jejunal wall and upper gastrointestinal endoscopic findings including hemorrhagic- erosive duodenitis, in children with GI symptoms, should be considered a manifestation of HSP, even in the absence of skin lesion.

Å°¿öµå

Henoch-Sch nlein purpura;Gastrointestinal symptoms;Ultrasonography;Endoscopy

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS